APEIRON Biologics announces financing round for the further development of the COVID-19 drug APN01

Written by Petra Hegmann on 18th May 2020. Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]